BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

836 related articles for article (PubMed ID: 18514969)

  • 1. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
    Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
    Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
    Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized mesoporous silica particles for application in drug delivery system.
    Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
    Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
    Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS
    J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
    Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
    Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release and intracellular protein delivery from mesoporous silica nanoparticles.
    Deodhar GV; Adams ML; Trewyn BG
    Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27973750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silica materials in drug delivery applications.
    Simovic S; Ghouchi-Eskandar N; Sinn AM; Losic D; Prestidge CA
    Curr Drug Discov Technol; 2011 Sep; 8(3):269-76. PubMed ID: 21291408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system.
    Knežević NŽ; Trewyn BG; Lin VS
    Chem Commun (Camb); 2011 Mar; 47(10):2817-9. PubMed ID: 21240408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-Regí M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
    Hu JJ; Xiao D; Zhang XZ
    Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles.
    Méndez J; Monteagudo A; Griebenow K
    Bioconjug Chem; 2012 Apr; 23(4):698-704. PubMed ID: 22375899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.